Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer

Squamous cell carcinoma of the oesophagus (SCCO) is still a pathology of bad prognosis. Specific therapies are now developed against epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2, c-kit receptor (CD117), vascular endothelial growth factor (VEGF) and p53 protein. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibault, L, Metges, J-P, Conan-Charlet, V, Lozac'h, P, Robaszkiewicz, M, Bessaguet, C, Lagarde, N, Volant, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361490/
https://www.ncbi.nlm.nih.gov/pubmed/15986037
http://dx.doi.org/10.1038/sj.bjc.6602625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361490/
https://www.ncbi.nlm.nih.gov/pubmed/15986037
http://dx.doi.org/10.1038/sj.bjc.6602625

Ejemplares similares